It was found that acute co-infusion of low doses of GLP-1 and native glucagon reduced food intake and increased energy expenditure to a greater extent than was achieved with either peptide infused alone [89, 90]
doi:10.1056/NEJMoa2410819 16
They named it glucagon-like peptide 1 (GLP-1)
[DOI] [PMC free article] [PubMed] [Google Scholar] 138.Checchia G.A., Letizia Mauro G., Morico G., Oriente A., Lisi C., Polimeni V., Ranieri L.M
Since then, multiple studies have systematically analyzed comorbidity relations and constructed networks based on epidemiological evidence
Other factors, including diet, exercise, and how their body reacts to the medication, will affect weight loss